Ketamine successfully terminates malignant status epilepticus

Epilepsy Research

Volumn 82, Issue 2-3, 2008, Pages 219-222

  Prüss, Harald ^a   Holtkamp, Martin ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

GABAergic inhibition; Intravenous anesthetics; Ketamine; Receptor trafficking; Status epilepticus

Indexed keywords

5 HYDROXYPROPAFENONE; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; ETIRACETAM; KETAMINE; LORAZEPAM; MIDAZOLAM; PHENYTOIN; PROPOFOL; THIOPENTAL; TOPIRAMATE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTINUOUS INFUSION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG TREATMENT FAILURE; ELECTROENCEPHALOGRAPHY; EPILEPTIC STATE; FEMALE; FOCAL EPILEPSY; GRAND MAL SEIZURE; HUMAN; LOADING DRUG DOSE; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; TONIC CLONIC SEIZURE; TREATMENT OUTCOME;

ANESTHESIA, GENERAL; ANESTHETICS, DISSOCIATIVE; ANTICONVULSANTS; COMA; DNA-DIRECTED DNA POLYMERASE; DRUG RESISTANCE, MULTIPLE; DRUG THERAPY, COMBINATION; ELECTROENCEPHALOGRAPHY; EPILEPSY, PARTIAL, MOTOR; EPILEPSY, TONIC-CLONIC; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; KETAMINE; MIDAZOLAM; MITOCHONDRIAL ENCEPHALOMYOPATHIES; QUADRIPLEGIA; RECURRENCE; STATUS EPILEPTICUS; YOUNG ADULT;

EID: 56449103912     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2008.08.005     Document Type: Article

References (24)

1. Bleck T.P. Refractory status epilepticus in 2001. Arch. Neurol. 59 (2002) 188-189
2. Bleck T.P., Quigg M., Nathan B.R., Smith T.L., and Kapur J. Electroencephalographic effects of ketamine treatment for refractory status epilepticus. Epilepsia 43 Suppl. 1 (2002) 282
3. Borris D.J., Bertram E.H., and Kapur J. Ketamine controls prolonged status epilepticus. Epilepsy Res. 42 (2000) 117-122
4. Claassen J., Hirsch L.J., Emerson R.G., and Mayer S.A. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia 43 (2002) 146-153
5. Coeytaux A., Jallon P., Galobardes B., and Morabia A. Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR). Neurology 55 (2000) 693-697
6. DeLorenzo R.J., Hauser W.A., Towne A.R., Boggs J.G., Pellock J.M., Penberthy L., Garnett L., Fortner C.A., and Ko D. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 46 (1996) 1029-1035
7. Holtkamp M., Othman J., Buchheim K., Masuhr F., Schielke E., and Meierkord H. A "malignant" variant of status epilepticus. Arch. Neurol. 62 (2005) 1428-1431
8. Holtkamp M., Othman J., Buchheim K., and Meierkord H. Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J. Neurol. Neurosurg. Psychiatry 76 (2005) 534-539
9. 2+ sensitivity of hippocampal dentate granule cell GABAA receptors. J. Neurosci. 17 (1997) 7532-7540
10. Kozinn J., Mao L., Arora A., Yang L., Fibuch E.E., and Wang J.Q. Inhibition of glutamatergic activation of extracellular signal-regulated protein kinases in hippocampal neurons by the intravenous anesthetic propofol. Anesthesiology 105 (2006) 1182-1191
11. Liu H., Dai T., and Yao S. Effect of thiopental sodium on N-methyl-d-aspartate-gated currents. Can. J. Anaesth. 53 (2006) 442-448
12. Lowenstein D.H., and Alldredge B.K. Status epilepticus at an urban public hospital in the 1980s. Neurology 43 (1993) 483-488
13. Martin B.S., and Kapur J. A combination of ketamine and diazepam synergistically controls refractory status epilepticus induced by cholinergic stimulation. Epilepsia 49 (2008) 248-255
14. Mazarati A.M., and Wasterlain C.G. N-methyl-d-asparate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat. Neurosci. Lett. 265 (1999) 187-190
15. Meierkord H., and Holtkamp M. Non-convulsive status epilepticus in adults: clinical forms and treatment. Lancet Neurol. 6 (2007) 329-339
16. Naylor D.E., Liu H., and Wasterlain C.G. Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus. J. Neurosci. 25 (2005) 7724-7733
17. Rice A.C., and DeLorenzo R.J. N-methyl-d-aspartate receptor activation regulates refractoriness of status epilepticus to diazepam. Neuroscience 93 (1999) 117-123
18. Rossetti A.O., Logroscino G., and Bromfield E.B. Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Arch. Neurol. 62 (2005) 1698-1702
19. Sheth R.D., and Gidal B.E. Refractory status epilepticus: response to ketamine. Neurology 51 (1998) 1765-1766
20. Treiman D.M., Walton N.Y., and Kendrick C. A progressive sequence of electroencephalographic changes during generalized convulsive status epilepticus. Epilepsy Res. 5 (1990) 49-60
21. Tzoulis C., Engelsen B.A., Telstad W., Aasly J., Zeviani M., Winterthun S., Ferrari G., Aarseth J.H., and Bindoff L.A. The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases. Brain 129 (2006) 1685-1692
22. Ubogu E.E., Sagar S.M., Lerner A.J., Maddux B.N., Suarez J.I., and Werz M.A. Ketamine for refractory status epilepticus: a case of possible ketamine-induced neurotoxicity. Epilepsy Behav. 4 (2003) 70-75
23. Vasile B., Rasulo F., Candiani A., and Latronico N. The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med. 29 (2003) 1417-1425
24. Wasterlain C., Liu H., Mazarati A., and Baldwin R. NMDA receptor trafficking during the transition from single seizures to status epilepticus. Ann. Neurol. 52 Suppl. 1 (2002) 16